Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan - NIPPON DATA90

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 954-959

  Nakamura, Koshi ^a   Okamura, Tomonori ^a   Hayakawa, Takehito ^b   Kadowaki, Takashi ^a   Kita, Yoshikuni ^a   Ohnishi, Hirofumi ^c   Saitoh, Shigeyuki ^c   Sakata, Kiyomi ^d   Okayama, Akira ^e   Ueshima, Hirotsugu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiovascular disease; Chronic kidney disease; Glomerular filtration rate; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY CARE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; JAPAN; KIDNEY FUNCTION; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POPULATION RESEARCH; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COHORT STUDIES; DATA COLLECTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 33746736235     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.954     Document Type: Article

References (30)

1. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41: 47-55.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
3. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
4. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236.
5. Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006; 69: 1264-1271.
6. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35: 681-689.
7. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
8. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44: 198-206.
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
10. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147 (erratum: Ann Intern Med 2003; 139: 605).
11. Ohmit SE, Flack JM, Peters RM, Brown WW, Grimm R. Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP). J Am Soc Nephrol 2003; 14(Suppl 2): S117-S121.
12. Owen WF Jr. Patterns of care for patients with chronic kidney disease in the United States: Dying for improvement. J Am Soc Nephrol 2003; 14(Suppl 2): S76-S80.
13. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253: 169-180.
14. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Elliott P, et al. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004; 147: 1024-1032.
15. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, et al. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 2004; 35: 1836-1841.
16. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H; The NIPPON DATA90 Research Group. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 2006; 184: 143-150.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
18. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000; 11: A0828.
19. Imai E, Horio M. Epidemiology of chronic kidney disease: The difference between Japan and Western countries. J Blood Press 2006; 13: 359-363 (in Japanese).
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
21. Fujimoto S, Watanabe T, Sakamoto A, Yukawa K, Morimoto K. Studies on the physical surface area of Japanese. 18: Calculation formulas in three stages over all ages. Nippon Eiseigaku Zasshi 1968; 23: 443-450 (in Japanese).
22. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003; 10: 145-153.
23. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Littleton: John Wright-PSG Inc, 1982.
24. Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, et al; ILSA Working Group. Atherosclerotic risk factors and renal function in the elderly: The role of hyperfibrinogenaemia and smoking: Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005; 20: 114-123.
25. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: The Hisayama study. Am J Kidney Dis 2004; 44: 437-445.
26. Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arterioscler Thromb Vasc Biol 1997; 17: 2554-2558.
27. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210.
28. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
29. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998; 32: 853-906.
30. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35(Suppl 1): S117-S131.